Novel neuroprotector successfully reduces brain damage after stroke in preclinical studies.

After suffering a stroke, which is estimated to kill more than 6 million people annually, about three-quarters of patients exhibit some disability.  It is known that most strokes occur when a disruption of blood flow prevents oxygen and glucose from reaching brain tissue, ultimately killing neurons and other cells. Therefore, the extent of a patient’s symptoms depends on the degree and location of brain tissue … Continue reading Novel neuroprotector successfully reduces brain damage after stroke in preclinical studies.